Trial Profile
Incretin-based therapy in preclinical type 1 diabetes in adults
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 07 Jan 2022 Planned End Date changed from 1 Jun 2019 to 1 Jun 2024.
- 07 Jan 2022 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2024.
- 15 Sep 2016 Planned End Date changed from 1 Dec 2018 to 1 Jun 2019.